Summary The effects of butyrate and retinoic acid in combination with catecholamines or histamine on the HN-1 human head and neck squamous carcinoma cell line were investigated analysing cell proliferation, placental alkaline phosphatase (PLAP) activity, and relative cytokeratin content.
Squamous cell carcinomas of the head and neck region often contain large keratinized patches of well differentiated squamous cells embedded in nests of less differentiated tumour cells. The malignant stem cell compartment in the tumour presumably gives rise to a progeny of cells that either continues to proliferate or acquires differentiation characteristics which finally gives rise to terminally matured end-stage cells.
As is shown in numerous reports, butyrate, retinoic acid, interferon, glucocorticoids, polar solvents, and certain chemotherapeutic agents can modulate terminal differentiation (Augeron & Laboisse, 1984; Burke, 1986; Jetten, 1984; Reiss et al., 1985; Sartorelli, 1985) , accompanied by inhibition of proliferation (Pierce & Wallace, 1971; Prasad & Sinha, 1976) , morphological changes (Abe & Kufe, 1984; Kamech et al., 1986) , and an increase in the production of specific antigens and enzymes (Reese & Politano, 1981; Morita et al., 1982; Abe & Kufe, 1984; Reese et al., 1985) , such as CEA and alkaline phosphatase. These effects were in most cases reversible, although some authors claimed a more permanently affected cell progeny after treatment (Augeron & Laboisse, 1984; Reiss et al., 1985) . It was indicated that for example butyrate and retinoic acid provided a trigger mechanism, which if properly administered to a cell would eventually lead to a terminally matured tumour cell.
Recently it was shown that cAMP-elevating agents like catecholamines, potentiated the action of retinoic acid in eliciting normal epithelial cell differentiation (Schiff & Moore, 1985) . Catecholamines have other intriguing effects on cells, including regulation of cell division (Kennedy et al., 1985; Tutton & Barkla, 1980) , induction of alkaline phosphatase (Mary & Rao, 1981) , and reduction of the total number of EGF receptors (Cruise et al., 1986) . In the light of the increased number of EGF receptors on malignant squamous cells the aforementioned effect might be very promising (Cowley et al., 1986) .
The present study, using HN-1 squamous carcinoma cells, demonstrated that butyrate inhibited clonogenicity in soft agar, enhanced placental alkaline phosphatase (PLAP) activity, and increased relative cytokeratin content, in contrast to retinoic acid. Retinoic acid, however, inhibited the enhancement of PLAP activity induced by butyrate.
Receptor studies with HN-1 cells showed that fl-adrenergiclike receptors were present (Bijman et al., 1987) . In view of the diverse effects of catecholamines on tumour cells, combinations with butyrate or retinoic acid were examined.
Materials and methods

Chemicals
Drugs used were (± )epinephrine, (± )norepinephrine, (± )isoproterenol, dopamine, histamine, (± )propranolol, cimetidine, phentolamine (Ciba Geigy), sodium butyrate, and all-trans-retinoic acid. For enzyme analysis 4-methylumbelliferyl phosphate (4-MUP), 4-methylumbelliferyl (4-MU), and 2-amino-2-methyl-1, 3-propanediol were used. The 4-MUP was purified before use to remove traces of free 4-MU. For DNA analysis 4',6-diamidino-2-phenylindole (DAPI, Boehringer) was used. All chemicals without company name acknowledged in parentheses were from Sigma.
Cell culture An established cell line, designated HN-1, was used for the present experiments. The cell line was derived from a human squamous cell carcinoma of the tongue (Easty et al., 1981) For cytokeratin analysis ethanol fixed cells were labeled (30 min) with K-40, which is a broadly cross-reacting polyclonal antibody for cytokeratins as described elsewhere (Ramaekers et al., 1984; Bijman et al., 1986) or with 4 different monoclonal antibodies i.e., RCK-102, RCK-105, RKSE-60, and RCK-106, analysing cytokeratins 5+8, 7, 10, and 18 respectively (Ramaekers et al., 1983) . For classification see Moll et al. (1982) . Cells were washed 3 times with PBS plus 5% FBS and subsequently labeled with a FITCconjugated second antibody. Cells were washed 3 times and stained with propidium iodide (15 jygml-1), to perform twocolour (green vs. red) fluorescence measurements. The data accumulated were directly stored on hard disc using a Digital PDP-1 I computer. Generally 30,000 cells were analysed for each measurement.
Biochemical analysis From stationary growth phase cultures (7 days in culture) 105 cells were subcultured in 25cm2 flasks in 4 ml MEM plus 10% FBS. After a 4 day exponential growth period, cells were treated with either butyrate (2 mM) or retinoic acid (10-9 M). Catecholamines, histamine, and antagonists were added to the medium 24 h after the start of butyrate or retinoic acid treatment, without changing the medium. Cells were trypsinized, centrifuged in MEM plus 10% FBS (5 min, 200 g), and resuspended in 1 mg ml-bovine serum albumin (BSA) in water. All specimens were stored for up to 3 days at -80°C. Cells were lysed using one cycle of freeze-thawing followed by sonication (10 sec-twice; amplitude of 12 micron; Soniprep 150, MSE). Suspensions were incubated at 62°C overnight in a water bath (17 h) to inactivate all nonplacental isoenzymes and centrifuged for S min at 2000g.
Placental alkaline phosphatase (PLAP) activity was determined as described elsewhere (Mier & Rennes, 1982a) . Briefly, the PLAP reagent contained final concentrations of 0.5mM 4-MUP (diluted from purified stock solution), 5mMNaF, and 100mM 2-amino-2-methyl-1, 3-propanediol at pH 9.8. The reaction was initiated by the addition of 204u1 reagent to 400 u1 sample. After an incubation period of I h at 37°C, the tubes were transferred to ice and I ml carbonate-bicarbonate buffer (200 mM, pH 10.5) was added.
Fluorescence was measured at Aex = 372 nm and Aem = 438 nm (Aminco, Bowman). After subtraction of the blank, the 4-MU liberated was calculated using a reference standard of I gM 4-MU in carbonate-bicarbonate buffer.
DNA content of the specimens was determined as the fluorescent complex with DAPI by adding 50 p1 of a 20ngml-l DAPI solution in 10mM Tris/HCl with ph7.0 (Mier & Rennes, 1982b) . Fluorescence was measured at Rex = 372 nm and )em=438 nm. DNA from calf thymus was used as standard (400 g ml-1 in 5 ml NaOH). All assays were carried out in duplicate and appropriate controls were included. PLAP activity was expressed as pmol 4-MU released min 1 g 1 DNA.
Results
Effect of butyrate and retinoic acid on proliferation
The effect of butyrate (0.5-2.5 mM) and retinoic acid (101 10-7 M) on the proliferation of HN-1 cells was monitored after a 3 day pretreatment of cells in the exponential growth phase or treatment during colony growth in soft agar. Butyrate inhibited colony growth of HN-1 cells in a dosedependent manner, when continuously present. Complete inhibition of colony growth occurred at 2.5mM butyrate ( Figure IA) . Pretreatment with various concentrations of butyrate for 3 days and subsequent culture produced a minor inhibition. In contrast retinoic acid when continuously present exhibited a small inhibitory effect on colony growth. However, pretreatment for 3 days with various concentrations of retinoic acid increased clonogenicity ( Figure 1B) . The average size of the colonies increased (data not shown) compared to controls. Figure 3 , 2mM butyrate induced a significant time related activation of PLAP. After 72 h the PLAP activity was enhanced approximately 10-fold compared to untreated cells. Retinoic acid (10 -9 M) had a small but insignificant effect on PLAP activity. Figure 4 shows that pretreatment of exponentially growing HN-1 cells with 10-8M retinoic acid for 24h inhibited the stimulatory effect on PLAP activity of a subsequent 48 h combined incubation with butyrate (0.5-2.5 mM).
The effect of catecholamines and histamine on PLAP activity
Catecholamine and histamine receptor involvement was investigated using several ligands. As shown in Figure 5 epinephrine, norepinephrine, and dopamine had no effect on PLAP activity, whereas isoproterenol and histamine produced a small activation of PLAP compared to untreated cells. A 24h pretreatment with 2mM butyrate, followed by a combined treatment for 24h with one of the catecholamines or histamine produced a synergistic enhancement of PLAP activity compared to PLAP activity in butyrate treated (48 h) cells. Pretreatment with 10-9M retinoic acid followed by a combined treatment with catecholamines or histamine had no effect on PLAP activity compared to the PLAP activity in retinoic acid treated cells. Relative PLAP activity
The effect of butyrate and retinoic acid on cytokeratins Figure 7A shows a flow cytometric analysis iof relative cytokeratin content and relative DNA content of cells exponentially growing for 4 days. In Figure 7B , C are documented the effects of 10-9 M retinoic acid and 2mM butyrate treatment (48 h) on relative keratin content respectively. Butyrate ( Figure 7C ) clearly enhanced the relative keratin content, whereas retinoic acid exerted no effect. The data on retinoic acid treated cells ( Figure 7B ) are comparable with those obtained with control cultures (48 h).
Further investigations using 4 monoclonal antibodies with which cytokeratins 5+8, 7, 10, and 18 can be distinguished, showed that butyrate increased labeling of cytokeratins 5+8 (Table I) , whereas with retinoic acid again no effect was detectable. The effect of antagonists on PLAP activity Dose response curves of the antagonists propranolol and phentolamine on PLAP activity are shown in Figure 6 . Pretreatment of cells with 2mM butyrate (24 h) followed by a combined treatment (24 h) of butyrate with 10 M isoproterenol plus the indicated concentrations of propranolol produced a partial inhibition of PLAP activity. In contrast, phentolamine produced an enhancement of PLAP activity compared to control cells treated with norepinephrine plus butyrate. Cimetidine (H2 antagonist) had no effect on PLAP activity induced by histamine plus butyrate (data not shown). 
Discussion
The results of this report confirmed the observations made by numerous investigators concerning the effect of sodium butyrate on tumour cells (Morita et al., 1982; Augeron & Laboisse, 1984; Reese et al., 1985) . Butyrate increased or diminished the activities of several enzymes depending on the cell type under investigation (Prasad, 1980) or influenced the production of certain proteins, i.e. a-foetoprotein, albumin, or carcinoembryonic antigen (Abe & Kufe, 1984; Nakagawa et al., 1985) . These changes in gene expression were most aamplifier gain was set with control cells using RCK-102, until a similar multiparameter display was obtained as shown in Figure 7A ; b +' =positive staining (compare with Figure 7A) ; '+ +' =enhanced staining (compare with Figure 7C ); '±'=less staining than control (compare with Figure 7B ).
probably due to alterations in chromatin structure (Kitzis et al., 1980) and the increased chromatin acetylation (Riggs et al., 1977) , which induced an increase in transcription.
In this study we have presented well documented results in which modulation of cell proliferation, PLAP activity, and relative keratin content have been attributed to a responsiveness to butyrate and retinoic acid which are believed to be strong modulators of maturation (Augeron & Laboisse, 1984) . Note the strong (Figure 4) and their subsequent coupling to adenylate cyclase , which greatly strengthens the latter hypothesis. It might explain why phentholamine plus norepinephrine induced a higher PLAP activity in butyrate treated cells. Phentholamine inhibited a-adrenergic receptors, enabling more binding of norepinephrine to f3-adrenergic receptors, which were already increased in number by butyrate.
In normal human keratinocytes vitamin A exerted a prominant effect on the type of keratin synthesized (Fuchs & Green, 1981; Kim et al., 1984) . Therefore, enhancement of cytokeratin content (cytokeratins 5+8) induced by butyrate and not by retinoic acid was very interesting. It is tempting to assume that correlation of certain biochemical changes in the cell with cessation of cell proliferation may imply differentiation to a more mature phenotype. However, it is pertinent to note that still many important questions concerning links to cell maturation need to be answered unambiguously. It indicated that the use of alternative characterization techniques is warranted, including more research on the type of keratin expressed (Kim et al., 1984; Moll et al., 1982) , possible detection of the precursor protein involucrin of the cornified envelope (Reiss et al., 1985) , or analysis of possible transglutaminase activity induced by differentiation-inducing agents (Mier et al., unpublished results) .
In conclusion, butyrate enhanced PLAP activity, which could be inhibited by retinoic acid or synergistically enhanced by butyrate plus catecholamines. The results obtained with antagonists showed that the effect on PLAP activity was exerted by stimulation of catecholamine-like receptors. Furthermore, butyrate increased cytokeratin content of HN-1 cells, which appeared to be due to keratins 5+8.
